Review



human cadaveric smc-deposited ecm  (Humacyte Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Humacyte Inc human cadaveric smc-deposited ecm
    Summary of TEVG studies that involved clinical trials and large animal models
    Human Cadaveric Smc Deposited Ecm, supplied by Humacyte Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+smc%E2%80%91deposited+ecm/pmc11468936-3-0-54?v=Humacyte+Inc
    Average 90 stars, based on 1 article reviews
    human cadaveric smc-deposited ecm - by Bioz Stars, 2026-07
    90/100 stars

    Images

    1) Product Images from "Immunomodulation Strategies for the Successful Regeneration of a Tissue‐Engineered Vascular Graft"

    Article Title: Immunomodulation Strategies for the Successful Regeneration of a Tissue‐Engineered Vascular Graft

    Journal: Advanced Healthcare Materials

    doi: 10.1002/adhm.202200045

    Summary of TEVG studies that involved clinical trials and large animal models
    Figure Legend Snippet: Summary of TEVG studies that involved clinical trials and large animal models

    Techniques Used: Clinical Proteomics, In Vivo, Infection



    Similar Products

    human cadaveric smc-deposited ecm  (Humacyte Inc)
    90
    Humacyte Inc human cadaveric smc-deposited ecm
    Summary of TEVG studies that involved clinical trials and large animal models
    Human Cadaveric Smc Deposited Ecm, supplied by Humacyte Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+smc%E2%80%91deposited+ecm/pmc11468936-3-0-54?v=Humacyte+Inc
    Average 90 stars, based on 1 article reviews
    human cadaveric smc-deposited ecm - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    human smc‑deposited ecm  (Humacyte Inc)
    90
    Humacyte Inc human smc‑deposited ecm
    Summary of TEVG studies that involved clinical trials and large animal models
    Human Smc‑Deposited Ecm, supplied by Humacyte Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+smc%E2%80%91deposited+ecm/pmc11468936-2-0-28?v=Humacyte+Inc
    Average 90 stars, based on 1 article reviews
    human smc‑deposited ecm - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Summary of TEVG studies that involved clinical trials and large animal models

    Journal: Advanced Healthcare Materials

    Article Title: Immunomodulation Strategies for the Successful Regeneration of a Tissue‐Engineered Vascular Graft

    doi: 10.1002/adhm.202200045

    Figure Lengend Snippet: Summary of TEVG studies that involved clinical trials and large animal models

    Article Snippet: Human cadaveric SMC‐deposited ECM , Cell deposition and decellularization , 6 , Decellularized , In vivo (baboon model, arteriovenous access) , Patent for up to 6 months Patency rate was 88% No dilation and change in thickness for 24 weeks No sign of infection, calcification, aneurysmal dilation, and no substantial intimal hyperplasia , Niklason Lab/Humacyte , Dahl et al., 2011.

    Techniques: Clinical Proteomics, In Vivo, Infection

    Summary of TEVG studies that involved clinical trials and large animal models

    Journal: Advanced Healthcare Materials

    Article Title: Immunomodulation Strategies for the Successful Regeneration of a Tissue‐Engineered Vascular Graft

    doi: 10.1002/adhm.202200045

    Figure Lengend Snippet: Summary of TEVG studies that involved clinical trials and large animal models

    Article Snippet: Human SMC‐deposited ECM , Cell deposition and decellularization , 6 , Decellularized , Phase 2 Clinical trial as arteriovenous access and ongoing Phase 3 trial , , Niklason Lab/Humacyte , Kirkto et al., 2019.

    Techniques: Clinical Proteomics, In Vivo, Infection